Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes

Endocrinology(2024)10.1210/endocr/bqae111Source: DataRank Database

ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes is a research paper published in Endocrinology (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)Impact (FWCI 1.78)OA: hybridTopics (59)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Hunter Waltermire,Kanako Mori,Zheqi Li ORCID,Yiting Li ORCID,Hannah Guzolik

Live enrichment

PubMed:39207954 PMC:PMC11384147 OpenAlex:https://openalex.org/W4401984416

National Cancer Institute

Grant: F30CA250167

National Cancer Institute

Grant: R01CA256161

National Cancer Institute

Grant: R01CA181368

National Cancer Institute

Grant: R01CA183976

National Cancer Institute

Grant: R21CA237964

UPMC Hillman Cancer Biology Program

Grant: P30CA047904-31

University of Pittsburgh

Grant: RRID:SCR_022735

National Institutes of Health

Grant: S10OD028483

NCI NIH HHS

Grant: P30 CA047904

National Institutes of Health

Grant: 5R01CA256161-03

Estrogen receptor fusions genes as drivers of endocrine resistance in breast cancer

National Institutes of Health

Grant: 5R01CA183976-02

CHARACTERIZATION OF RECURRENT ADJACENT GENE TRANSLOCATIONS IN BREAST CANCER

National Institutes of Health

Grant: 1R21CA237964-01A1

Characterization of EPHA3 intragenic rearrangements in high-grade serous carcinoma progression and recurrence

National Institutes of Health

Grant: 1S10OD028483-01A1

High-Throughput Computing for Genomics and Bioinformatics Research

National Institutes of Health

Grant: 5R01CA181368-02

Integrative Consig: NLK as Attractive Drug Target for Intractable Breast Cancer

National Institutes of Health

Grant: 3P30CA047904-07S1

CANCER CENTER SUPPORT GRANT

National Institutes of Health

Grant: 5F30CA250167-05

Functional Characterization and Clinical Prevalence of ESR1 Fusions in Advanced Endocrine Resistant Breast Cancer

Breast Cancer Alliance

The Breasties

Pennsylvania Department of Health

Hillman Foundation

Shear Family Foundation

PA Breast Cancer Coalition

FWCI

1.78

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://academic.oup.com/endo/advance-article-pdf/doi/10.1210/endocr/bqae111/58965771/bqae111.pdf

publisherhttps://academic.oup.com/endo/advance-article-pdf/doi/10.1210/endocr/bqae111/58965771/bqae111.pdf

publisherhttps://academic.oup.com/endo/article-pdf/165/10/bqae111/59328291/bqae111.pdf

journalhttps://doi.org/10.1210/endocr/bqae111

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39207954

Fields of Study

Computational Drug Discovery Methodsbioluminescence and chemiluminescence researchEstrogen and related hormone effects0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

YAP-Signaling ProteinsBreast NeoplasmsFemaleHumansLigandsPhenotypeTranscription FactorsSignal TransductionOncogene Proteins, FusionGene Expression Regulation, NeoplasticCarcinoma, Ductal, BreastCarcinoma, LobularCell Line, TumorEstrogen Receptor alphaAdaptor Proteins, Signal TransducingCell ProliferationSOX9 Transcription Factor

Keywords

PhenotypeBreast cancerBiologyCancerInternal medicineCancer researchLigand (biochemistry)Oestrogen receptorEndocrinologyEstrogen receptorEstrogen receptor alphaGeneticsReceptorOncologyMedicineGeneFusionMetastasisEndocrine ResistanceIlcOncogene Proteins, FusionCarcinoma, Ductal, BreastBreast NeoplasmsYAP-Signaling ProteinsSOX9 Transcription FactorLigandsGene Expression Regulation, NeoplasticCarcinoma, LobularCell Line, TumorHumansFemaleResearch ArticleSignal TransductionTranscription FactorsAdaptor Proteins, Signal TransducingCell Proliferation

Sustainable Development Goals

SDG 0: Good health and well-being

ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes

FAIR Checklist

Authors (12)

Funding (22 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)